GAMMA Investing LLC Has $146,000 Stake in Universal Health Services, Inc. (NYSE:UHS)

GAMMA Investing LLC lowered its stake in Universal Health Services, Inc. (NYSE:UHS) by 6.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 814 shares of the health services provider’s stock after selling 59 shares during the period. GAMMA Investing LLC’s holdings in Universal Health Services were worth $146,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of UHS. Point72 Asset Management L.P. boosted its position in Universal Health Services by 362.3% in the 2nd quarter. Point72 Asset Management L.P. now owns 322,626 shares of the health services provider’s stock valued at $59,663,000 after buying an additional 252,846 shares during the last quarter. Marshall Wace LLP boosted its holdings in Universal Health Services by 357.9% in the second quarter. Marshall Wace LLP now owns 261,221 shares of the health services provider’s stock valued at $48,308,000 after acquiring an additional 204,178 shares during the last quarter. Mackenzie Financial Corp increased its position in Universal Health Services by 408.2% in the second quarter. Mackenzie Financial Corp now owns 140,561 shares of the health services provider’s stock worth $25,994,000 after purchasing an additional 112,902 shares during the period. Los Angeles Capital Management LLC raised its holdings in Universal Health Services by 102.0% during the 3rd quarter. Los Angeles Capital Management LLC now owns 210,926 shares of the health services provider’s stock worth $48,304,000 after purchasing an additional 106,517 shares during the last quarter. Finally, Renaissance Technologies LLC acquired a new position in Universal Health Services during the 2nd quarter valued at about $18,031,000. Institutional investors own 86.05% of the company’s stock.

Universal Health Services Price Performance

NYSE UHS opened at $190.65 on Friday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.28 and a current ratio of 1.39. The stock has a market cap of $12.58 billion, a price-to-earnings ratio of 12.68, a PEG ratio of 0.60 and a beta of 1.30. The business has a 50 day simple moving average of $193.14 and a 200 day simple moving average of $207.39. Universal Health Services, Inc. has a 52-week low of $150.11 and a 52-week high of $243.25.

Universal Health Services (NYSE:UHS) last issued its quarterly earnings data on Thursday, October 24th. The health services provider reported $3.71 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.75 by ($0.04). Universal Health Services had a return on equity of 15.75% and a net margin of 6.66%. The company had revenue of $3.96 billion for the quarter, compared to the consensus estimate of $3.90 billion. During the same period in the prior year, the company earned $2.55 EPS. The firm’s revenue was up 11.3% on a year-over-year basis. Analysts anticipate that Universal Health Services, Inc. will post 15.88 earnings per share for the current fiscal year.

Universal Health Services Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Tuesday, December 3rd were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 0.42%. The ex-dividend date was Tuesday, December 3rd. Universal Health Services’s dividend payout ratio is 5.32%.

Insider Activity

In other news, Director Maria Ruderman Singer sold 1,614 shares of the business’s stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $191.15, for a total value of $308,516.10. Following the sale, the director now owns 5,879 shares of the company’s stock, valued at $1,123,770.85. The trade was a 21.54 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 16.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on UHS shares. Barclays lifted their price target on shares of Universal Health Services from $256.00 to $271.00 and gave the stock an “overweight” rating in a research report on Friday, October 25th. Bank of America started coverage on shares of Universal Health Services in a research report on Wednesday, November 6th. They set a “neutral” rating and a $223.00 target price for the company. TD Cowen reduced their price target on Universal Health Services from $275.00 to $251.00 and set a “buy” rating on the stock in a research report on Tuesday, November 26th. Royal Bank of Canada decreased their price objective on Universal Health Services from $222.00 to $211.00 and set a “sector perform” rating for the company in a research note on Monday, October 28th. Finally, KeyCorp assumed coverage on Universal Health Services in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Seven equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $226.14.

Universal Health Services Profile

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.